Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphismDerek A. Oldridge, John M. Maris, Andrew Wood et al.|Nature|2015Cited by 303
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R. Bosse, John M. Maris, Pichai Raman et al.|Cancer Cell|2017Cited by 229
Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation SequencingBenjamin M. Manning, Saar Gill, Selina M. Luger et al.|Blood|2018Cited by 1